ML18001A001: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
Line 3: | Line 3: | ||
| issue date = 01/01/2018 | | issue date = 01/01/2018 | ||
| title = Exhibit List (Revised) of Northwest Medical Isotopes, LLC | | title = Exhibit List (Revised) of Northwest Medical Isotopes, LLC | ||
| author name = Haass | | author name = Haass C | ||
| author affiliation = Northwest Medical Isotopes, LLC | | author affiliation = Northwest Medical Isotopes, LLC | ||
| addressee name = | | addressee name = |
Revision as of 07:38, 18 June 2019
ML18001A001 | |
Person / Time | |
---|---|
Site: | Northwest Medical Isotopes |
Issue date: | 01/01/2018 |
From: | Haass C Northwest Medical Isotopes |
To: | NRC/OCM |
SECY RAS | |
References | |
50-609-CP, Construction Permit Mndtry Hrg, RAS 54140 | |
Download: ML18001A001 (4) | |
Text
Exhibit List (Docket No. 50-609-CP) 1 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION ) In the Matter of ) Docket No. 50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC ) ) (Medical Radioisotope Production Facility) ) January 1, 2018 ) EXHIBIT LIST NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING notice dated November 21, 2017, Northwest Medical Isotopes, LLC (NWMI) hereby submits its list of exhibits for the evidentiary hearing for Docket No. 50-609-CP to be held on January 23, 2018. Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title. Exhibit Number Panel Number/ Sponsoring Witness(es) Document Description/Title NWMI-001 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to -Hearing Questions NWMI-002 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to - Public Pre-Hearing Questions NWMI-003 Statement of Qualifications: Roy W. Brown, Ralph A. Butler, Michael R. Corum, Gary L. Dunford, Nicholas F. Fowler, Carolyn C. Haass, Stephen R. Reese Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application Exhibit List (Docket No. 50-609-CP) 2 Exhibit Number Panel Number/ Sponsoring Witness(es) Document Description/Title NWMI-004 Overview Panel: Roy W. Brown, Nicholas F. Fowler, Carolyn C. Haass, Stephen R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation NWMI-005 Safety Panel 1: Ralph A. Butler, Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Stephen R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation NWMI-006 Safety Panel 2: Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Stephen R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation NWMI-007 Environmental Panel: Michael R. Corum, Gary L. Dunford, Carolyn C. Haass, Stephen R. Reese Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation NWMI-008 Letters of Support: U.S. Senators Ron Wyden and Claire McCaskill; Boone County Commissioner Dan Atwill; Manager, City of Columbia, Missouri, Mike Mathis; Missouri Department of Economic Development, Terrance M. Maglich, Project Manager Federal, State of Missouri, City of Columbia, and Boone County letters of support for the construction and operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility NWMI-009 Missouri Department of Natural Resources Letter to Northwest Medical Isotopes, LLC, dated September 15, 2017 Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189 NWMI-010 Northwest Medical Isotopes, LLC Letter (NWMI-LTR-2017-016) to U.S. Nuclear Regulatory Commission, dated December 18, 2017 Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing for Northwest Medical Isotopes, LLC Radated December 18, 2017 NWMI-011 Carolyn C. Haass -Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Exhibit List (Docket No. 50-609-CP) 3 Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 1st day of January 2018 Certificate of Service (Docket No. 50-609-CP) UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION ) In the Matter of ) Docket No. 50-609-CP ) NORTHWEST MEDICAL ISOTOPES, LLC ) ) (Medical Radioisotope Production Facility) ) January 1, 2018 ) CERTIFICATE OF SERVICE I hereby certify that on this date, Isotopes, LLC for the Hearing on -011 were submitted through the NRC E-filing system. Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d) Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 1st day of January 2018